Gastrointestinal Infection Testing Market to Register Growth in Incremental Opportunity During the Forecast Period 2026

09/giu/2020 16:38:27 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

New York City, United States -- Since the COVID-19 infection flare-up in December 2019, the malady has spread to right around 100 nations around the world with the World Health Organization proclaiming it a general wellbeing crisis. The worldwide effects of the coronavirus sickness 2019 (COVID-19) are now beginning to be felt, and will essentially influence the Healthcare Industry in 2020.

Gastrointestinal (GI) infections are one of the most common infections in primary care. According to NCBI (National Center for Biotechnology Information), around 200 Mn GI infections occur in the U.S. annually. To detect bacteria, virus and parasites, gastrointestinal infection testing is done.

The molecular tool is used for fast discovery of bacteria in clinical specimens and allows early and clear laboratory validation of related diseases. Since the past few years, real-time PCR tests have been widely developed in clinical microbiology labs for routine gastrointestinal infection testing of infectious diseases, such as bacterial, viral and parasitic diseases.

Get Sample Copy of Report @

Company Profiles

  • Becton, Dickinson and Company (BD)
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Luminex Corporation
  • Hoffmann-La Roche Ltd.
  • bioMérieux SA
  • Quidel Corporation
  • Illumina, Inc.
  • Seegene Inc
  • Genetic Signatures
  • Others.

This factor will boost the growth of the gastrointestinal infection testing market during the forecast period. According to the latest report published by the company, the global gastrointestinal infection testing market is projected to account for over US$ 490.2 Mn, in terms of value, by 2026 end. The report further projects that the gastrointestinal infection testing market will grow at a CAGR of 5.1% through 2026.

Growing Usage of Sophisticated Infection Detection Panels and Infectious Testing Kits to Give a Boost to the Gastrointestinal Infection Testing Market

Diarrhea is one of the leading causes of deaths. According to WHO, diarrhea kills around 525 Mn children aged 5 years or less every year. Gastrointestinal infection testing is done using PCR systems that provide a quick valuation of gene mutations or the presence of antibiotic resistance genes.

This factor will increase the growth of the gastrointestinal infection testing market during the forecast period. That apart, increasing healthcare expenditure by governments has enabled the usage of sophisticated infection detection panels and infectious testing kits in hospitals, diagnostic laboratories and institutes.

Get To Know Methodology of Report @

This factor, in particular, is likely to play an instrumental role in driving the growth of the gastrointestinal infection testing market during the forecast period.

Asia Pacific Excluding China to Register Highest Growth Rate

Stringent rules and regulations set by the U.S. Food and Drug Administration (FDA) may hinder the growth of the gastrointestinal infection testing market. The North America gastrointestinal infection testing market is expected to give a boost to the growth of the gastrointestinal infection testing market due to increasing healthcare spending and government initiatives to spread awareness and availability of better gastrointestinal infection testing options in the region.

blog comments powered by Disqus è un servizio offerto da Factotum Srl